Quantinno Capital Management’s Precigen PGEN Stock Holding History

Quantinno Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$107K	Buy	+12,480	New	+$81.9K	﹤0.01%	3562

Other funds holding PGEN

Patient Capital Management Baltimore, Maryland $3.15B AUM 29.14% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return

Occam Crest Management Darien, Connecticut $188M AUM 69.74% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Quantinno Capital Management's PGEN Position: Q3 2026 in Review

Quantinno Capital Management opened a new position in Precigen (PGEN) in Q3 2026: 12,480 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #3562 among its holdings.

183 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

Quantinno Capital Management held 12,480 shares of Precigen worth $107K as of Q3 2026.
Precigen was a new Quantinno Capital Management position in Q3 2026.
Precigen made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3562 holding.
183 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.